Sources | Names Used |
---|---|
CTRPv2 | BRD-M00053801 |
PharmacoGx | BRD-M00053801 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CD164L2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | CFAP65 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | ANXA3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
mRNA | GADD45G | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | WDR33 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | RIPPLY2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
mRNA | C3orf67 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | LINGO1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | RNF2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | ENPP4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |